Top Markets
Coin of the day
Delta-Fly Pharma, Inc. Delta-Fly Pharma, Inc.

Delta-Fly Pharma, Inc.

4598
주식 순위 #32530
Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a... Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a biotechnology company focused on the development of innovative oncology drugs. Their comprehensive pipeline includes several drug candidates targeting various cancers. DFP-10917 is currently undergoing Phase III clinical evaluation in the United States and Phase I in Japan for relapsed/refractory acute myeloid leukemia. Another significant compound, DFP-14323, is in Phase III trials for lung cancer. The firm is also advancing DFP-17729 through Phase I/II studies for solid tumors. Furthermore, DFP-11207 has successfully completed its Phase I clinical trial for pancreatic cancer. For hematologic malignancies, DFP-14927 is in Phase I, while DFP-10825 is in preclinical development, targeting gastric and ovarian cancers.
주가
$0.69158324
시가총액
$9.84M
변동 (1일)
0.00%
변동 (1년)
-84.15%
국가
JP
거래 Delta-Fly Pharma, Inc. (4598)

카테고리

Delta-Fly Pharma, Inc. (4598)의 주가 이력
최고 종가: $0.69 (2026-08-01 기준)

최저 종가: $3.99 (2024-07-01 기준)
Delta-Fly Pharma, Inc.의 주가 이력 (2024 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -37.60%
2025 -13.51%
2024 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$515.58 31.26%
US
$992.01 51.72%
NL
$736.64 7.19%
CH
$1.07K -6.40%
KR
$255.50 13.38%
BE